University of Warwick formed a strategic partnership with the Liverpool School of Tropical Medicine (LSTM) in 2011 to support joined long –term research. This collaboration has resulted in research of direct relevance to improving the quality of health and social care and it had substantial influence on policy and practice.
Primary research at Warwick covers wide range of areas, in particular depression, pain, falls, fractures, cardiac arrest, intensive care and public mental health. Our secondary research also addresses key NHS priorities. Warwick researchers established a technology appraisal group Warwick Evidence which produces health technology assessment reports, mostly for NICE.
Warwick research has established the importance of parenting in child development and it has highlighted wellness as an important outcome from health and social care interventions. The Warwick Edinburgh Mental Wellbeing Scale is established as the brand leader for measuring wellness. Our research has made the transition from child to adult mental health care a national and international priority.
Commercialising intellectual property
Warwick Ventures Limited (WVL) is a whole owned subsidiary commercialising innovations resulting from research of the University. It offers advice and services that support academics working on innovations and it works closely with industry via specialist commercialisation managers linking business and investors to the University’s intellectual property. WVL supports technology development and protects the intellectual property resulting from it. It is responsible for licensing, as well as creating spinout companies. Two important healthcare technologies that have been patented and commercialised with WVL are: Kingmark, used worldwide, making hip replacement surgery safer, quicker and more precise and TrueCPRTM developed with industrial partners to correct errors in their resuscitation monitoring devices.
Science City Research Alliance
Science City Research Alliance (SCRA) is a collaboration between the Universities of Birmingham and Warwick. With the budget of £55 million it is a key component of Warwick Medical School approach to impact. The SCRA is aimed at delivering a vibrant knowledge-led economy in the West Midlands by delivering new models of partnership with the local industry, particularly with small and medium sized businesses. Among others it enabled capital investment into a new, state of the art clinical trials unit to support applied health research.
Key Research Team Members
- Professor ...